Contract Manufacturing Industry News

  1. Company Recognized For Outstanding Contributions To The Pharmaceutical Sciences 5/30/2012

     Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that The American Association of Pharmaceutical Scientists (AAPS) has awarded its 2012 Excellence in Ligand Binding Assays Award to the Bioanalytical Development group from Morphotek for their abstract, “Development and Validation of a Pharmacokinetic Assay on the Gyrolab Platform for Use in Phase II/III Clinical Studies.” The award was presented at the AAPS 2012 National Biotechnology Conference held May 21-23 in San Diego.
     

  2. Recipharm Secures Financing For Future Growth 5/23/2012

    The company earmarks new EUR 90 million loan facility for further acquisition of niche CDMOs, investment in existing facilities and building long term partnerships with major pharmaceuticals companies.

  3. Veeda Oncology Joins OmniComm's CRO Preferred Program And Signs Agreement For First Study 5/23/2012

    OmniComm Systems, Inc. (OTCBB: OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, today announced that Veeda Clinical Research Inc., also known as Veeda Oncology®, has joined OmniComm's CRO Preferred Program, and as part of this program has signed an agreement to run their first study; a 27 month, phase I oncology trial.

  4. Dr. Reddy's Announces The Launch Of Over-The-Counter Lansoprazole Delayed-Release Capsules 5/21/2012

    Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched over-the-counter (OTC) Lansoprazole delayed-release capsules in the US market on May 18, 2012 following Dr. Reddy’s ANDA approval by the United States Food & Drug Administration (USFDA).

  5. Viropro, Inc. To Unlock Value From Its Biosimilars Portfolio 5/21/2012

    Viropro, Inc. creates a technology subsidiary to focus on the burgeoning International market for biosimilar drug therapeutics. Over the past year, several of the large pharmas have tied up with Contract Research Organizations (CROs) and/or with Contract Manufacturing Organizations (CMOs) to enter the field of biosimilars.

  6. SGS Acquires Vitrology Limited, Glasgow, UK And Enhances Offering For Biologic Therapeutics Testing 5/21/2012

    SGS announced on May 18th the acquisition of Vitrology Limited based in Glasgow, UK. Vitrology is a biopharmaceutical Contract Testing Organisation and a dynamic force in the biosafety testing sector of the pharmaceutical industry. 

  7. Evotec Becomes The First Contract Research Facility In Europe To Offer Agilent's RapidFire/MS Screening For Pharmaceutical Drug Discovery 5/16/2012

    Evotec AG is proud to announce the addition of Agilent Technologies' RapidFire Mass Spectrometry analysis capabilities to their High Throughput Screening facilities in Hamburg.

  8. Avalanche Biotechnologies, Inc. And Lonza Announce Global Manufacturing Collaboration For Adeno-Associated Viral Vectors For Gene Therapy 5/16/2012

    Avalanche Biotechnologies, Inc., a leader in the area of long-term protein delivery for ocular diseases, and Lonza, a global leader in the field of biologics manufacturing, recently announced a manufacturing collaboration focused on process development and scale-up efforts for the manufacturing of adeno-associated viral (AAV) vectors for gene therapy.

  9. Contract Manufacturing In India And China Backed By Government Policies 5/16/2012

    Contract Manufacturing Organizations (CMO) will reap the rewards as pharmaceutical production becomes increasingly globalized, according to a new report by business intelligence experts GBI Research.

  10. Contract Research Organizations Set To Experience Rapid Growth As Development Costs For New Drugs Continue To Rise 5/15/2012

    Global Information Inc. is pleased to announce two significant new reports on Drug Development: